Literature DB >> 920708

Severe chronic active liver disease. Prognostic significance of initial morphologic patterns.

S W Schalm, M G Korman, W H Summerskill, A J Czaja, A H Baggenstoss.   

Abstract

To determine the usefulness of recognizing the different morphologic patterns of chronic active liver disease (CALD), we compared clinical and biochemical features as well as responses to treatment in 32 patients with chronic active hepatitis (CAH); 36 with subacute hepatitis and bridging necrosis (SHB); 30 with subacute hepatitis and multilobular necrosis (SHMN); and 30 with cirrhosis and active hepatitis (Cirrh). The morphological lesions did not correlate with clinical or etiologic features. Patients with CAH had less severe biochemical abnormalities, entered remission more often, and failed to respond to treatment less frequently than those with SHMN or Cirrh. SHB and SHMN resembled each other in many regards and showed greater functional changes than CAH. Cirrhosis developed more often after SHMN than CAH and was associated with a poorer prognosis than CAH. Serial liver biopsies revealed all possible histologic transitions, with reduction of inflammation usually occurring in patients treated with steroids and extension of inflammation being more frequent in those not receiving these drugs. CAH, SHB, SHMN, and Cirrh, therefore, reflect the degree and extent of disease activity at any given time in CALD, rather than representing different conditions. Identification of the initial morphologic lesion is helpful because of differences in prognosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 920708     DOI: 10.1007/bf01076196

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  13 in total

1.  Subacute hepatitis.

Authors:  W A TISDALE
Journal:  N Engl J Med       Date:  1963-01-10       Impact factor: 91.245

2.  Subacute hepatic necrosis and postnecrotic cirrhosis due to anicteric infections with the hepatitis virus.

Authors:  G KLATSKIN
Journal:  Am J Med       Date:  1958-09       Impact factor: 4.965

3.  Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis).

Authors:  J L Boyer; G Klatskin
Journal:  N Engl J Med       Date:  1970-11-12       Impact factor: 91.245

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

6.  Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution.

Authors:  A H Baggenstoss; R D Soloway; W H Summerskill; L R Elveback; L J Schoenfield
Journal:  Hum Pathol       Date:  1972-06       Impact factor: 3.466

7.  Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.

Authors:  R D Soloway; A H Baggenstoss; L J Schoenfield; W H Summerskill
Journal:  Am J Dig Dis       Date:  1971-12

8.  Classification and treatment of chronic active liver disease.

Authors:  M G Geall; L J Schoenfield; W H Summerskill
Journal:  Gastroenterology       Date:  1968-12       Impact factor: 22.682

9.  Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared.

Authors:  W H Summerskill; M G Korman; H V Ammon; A H Baggenstoss
Journal:  Gut       Date:  1975-11       Impact factor: 23.059

10.  Prognostic significance of subacute hepatic necrosis in acute hepatitis.

Authors:  A J Ware; E H Eigenbrodt; B Combes
Journal:  Gastroenterology       Date:  1975-03       Impact factor: 22.682

View more
  19 in total

Review 1.  Advances in the current treatment of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-04-03       Impact factor: 3.199

2.  Current status of therapy in autoimmune liver disease.

Authors:  Gideon M Hirschfield; Nadya Al-Harthi; E Jenny Heathcote
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

3.  Prognostic significance of bridging necrosis in chronic active hepatitis.

Authors:  T Okuno; T Okanoue; T Takino; K Mori
Journal:  Gastroenterol Jpn       Date:  1983-12

Review 4.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 5.  Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.

Authors:  Syed Rizvi; Samer Gawrieh
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

Review 6.  Acute and acute severe (fulminant) autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-10-23       Impact factor: 3.199

Review 7.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

8.  A study on the relationship between the prognosis of chronic active hepatitis and the HBV associated antigen/antibody systems.

Authors:  Y Kosaka; Y Tameda; Y Okuda; K Takase; H Sawa; H Takezawa
Journal:  Gastroenterol Jpn       Date:  1981-12

Review 9.  Drug therapy in the management of type 1 autoimmune hepatitis.

Authors:  A J Czaja
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

Review 10.  Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly.

Authors:  Albert J Czaja
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.